bibliographic entry 5530244 [be/5530244]
https://w3id.org/oc/corpus/be/5530244

is a

• bibliographic reference

content

• Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A et al. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. J Clin Oncol 2014; 32: 415–423. PMID: 24297946

references

• https://w3id.org/oc/corpus/br/4706932